Cat No.
CEI-0701
Description
An α ;-glucosidase inhibitor which induces an enhanced and prolonged release of glucagon-like peptide-1, regulating appetite and stabilizing body weight in humans. Displays anti-atherothrombotic effect by reducing platelet activation and raising circulating adiponectin levels in patients with type 2 diabetes. Clinically useful antidiabetic agent.
Alias
BAY-1099
Synonyms
BAY-1099
CAS No.
72432-03-2
Product_Overview
An α-glucosidase inhibitor
Targets
GAA
Chemical Name
(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(-(hydroxymethyl)piperidine-3,4,5-triol; N-(2-Hydroxyethyl)-1-deoxynojirimycin
M.Wt
301.32
Purity
>98% by HPLC
Appearance
Pale yelow solid
Solubility
DMSO (100 mM)
Storage
-20 centigrade
Shipping Conditions
Gel pack
Handling
Protect from air and light
Usage
For Research Use Only! Not For Use in Humans.
